{"product_id":"uscap-thorax-revisited-2026","title":"USCAP Thorax Revisited 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: pathologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOriginal release date: January 12, 2026\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003ePracticing academic and community pathologists, and pathologists-in-training\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this educational activity, learners will be able to:\u003c\/h3\u003e\n\u003cp\u003eUnderstand when molecular testing is needed for thoracic tumors, what tests are appropriate, and how to interpret the results.\u003c\/p\u003e\n\u003cp\u003eBecome familiar with morphologic features of various prevascular mediastinal lesions for establishing a reasonable differential diagnosis. Based on that differential diagnosis the participants will learn to apply reasonable small panels of ancillary tests, including immunostains and potentially cytogenetics (especially chromosome 12p alterations for germ cell tumors).\u003c\/p\u003e\n\u003cp\u003eBecome familiar with morphologic features of various non neoplastic lung diseases. Cases selected will span the spectrum of cellular and fibrotic interstitial pneumonias, smoking related disease, cystic lung disease, benign lymphoid lesions (and some neoplastic mimics), vascular disease, drug reactions, the lung in systemic disease, and various granulomatous diseases. These cases form the bulk of cases sent to our large consultation practice indicating that pathologists struggle with how to report their findings and to communicate the clinical significance of what they are seeing.\u003c\/p\u003e\n\u003cp\u003eUnderstand the various types of pleural lesions encountered in everyday practice, their morphologic differential and mimics, and what adjunctive tests are or are not useful in working up such cases.\u003c\/p\u003e\n\u003cp\u003eGain familiarity with the basics of thoracic cytology (lavage, EBUS, effusion) specimens, understand issues related to specimen preparation, and how and when to apply immunostains or FISH.\u003c\/p\u003e\n\u003cp\u003eLearn efficient use of immunostains for thoracic lesions and learn to recognize problems and misleading results with such stains.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBasics of Molecular Pathology – Yin (Rex) P. Hung, MD, PhD\u003c\/p\u003e\n\u003cp\u003eMediastinum – Anja C. Roden, MD\u003c\/p\u003e\n\u003cp\u003eIHC Pitfalls – Anja C. Roden, MD\u003c\/p\u003e\n\u003cp\u003ePleura – Andrew Churg, MD, PhD\u003c\/p\u003e\n\u003cp\u003eCytology – Andrew Churg, MD, PhD\u003c\/p\u003e\n\u003cp\u003eGross–Microscopic Correlations in Thoracic Pathology – Anja C. Roden, MD\u003c\/p\u003e\n\u003cp\u003eNon-Neoplastic: Part 1 – Henry D. Tazelaar, MD\u003c\/p\u003e\n\u003cp\u003eNon-Neoplastic: Part 2 – Henry D. Tazelaar, MD\u003c\/p\u003e\n\u003cp\u003eMolecular Testing: Part 1 – Yin (Rex) P. Hung, MD, PhD\u003c\/p\u003e\n\u003cp\u003eMolecular Testing: Part 2 – Yin (Rex) P. Hung, MD, PhD\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405738987716,"sku":null,"price":130.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/USCAP-Thorax-Revisited-2026.png?v=1784215507","url":"https:\/\/medicalcoursespro.com\/products\/uscap-thorax-revisited-2026","provider":"Medicalcoursespro","version":"1.0","type":"link"}